Effects of Hyperbaric Oxygen Therapy on Cerebral Oxygenation and Mitochondrial Function Following Moderate Lateral Fluid-percussion Injury in Rats
Overview
Affiliations
Object: In the current study, the authors examined the effects of hyperbaric O2 (HBO) following fluid-percussion brain injury and its implications on brain tissue oxygenation (PO2) and O2 consumption (VO2) and mitochondrial function (redox potential).
Methods: Cerebral tissue PO2 was measured following induction of a lateral fluid-percussion brain injury in rats. Hyperbaric O2 treatment (100% O2 at 1.5 ata) significantly increased brain tissue PO2 in both injured and sham-injured animals. For VO2 and redox potential experiments, animals were treated using 30% O2 or HBO therapy for 1 or 4 hours (that is, 4 hours 30% O2 or 1 hour HBO and 3 hours 100% O2). Microrespirometer measurements of VO2 demonstrated significant increases following HBO treatment in both injured and sham-injured animals when compared with animals that underwent 30% O2 treatment. Mitochondrial redox potential, as measured by Alamar blue fluorescence, demonstrated injury-induced reductions at 1 hour postinjury. These reductions were partially reversed at 4 hours postinjury in animals treated with 30% O2 and completely reversed at 4 hours postinjury in animals on HBO therapy when compared with animals treated for only 1 hour.
Conclusions: Analysis of data in the current study demonstrates that HBO significantly increases brain tissue PO2 after injury. Nonetheless, treatment with HBO was insufficient to overcome injury-induced reductions in mitochondrial redox potential at 1 hour postinjury but was able to restore redox potential by 4 hours postinjury. Furthermore, HBO induced an increase in VO2 in both injured and sham-injured animals. Taken together, these data demonstrate that mitochondrial function is depressed by injury and that the recovery of aerobic metabolic function may be enhanced by treatment with HBO.
Non-pharmacological interventions for traumatic brain injury.
Davis C, Arruri V, Joshi P, Vemuganti R J Cereb Blood Flow Metab. 2024; 44(5):641-659.
PMID: 38388365 PMC: 11197135. DOI: 10.1177/0271678X241234770.
Sakas R, Dan K, Edelman D, Abu-Ata S, Ben-Menashe A, Awad-Igbaria Y Antioxidants (Basel). 2023; 12(12).
PMID: 38136154 PMC: 10740762. DOI: 10.3390/antiox12122034.
Identifying the Target Traumatic Brain Injury Population for Hyperbaric Oxygen Therapy.
Schimmel S, Sayed B, Lockard G, Gordon J, Young I, DEgidio F Int J Mol Sci. 2023; 24(19).
PMID: 37834059 PMC: 10572450. DOI: 10.3390/ijms241914612.
Management Strategies Based on Multi-Modality Neuromonitoring in Severe Traumatic Brain Injury.
Lazaridis C, Foreman B Neurotherapeutics. 2023; 20(6):1457-1471.
PMID: 37491682 PMC: 10684466. DOI: 10.1007/s13311-023-01411-2.
Yan Y, Zhang X, An X, Fan W, Liang J, Luo B Front Neurol. 2022; 13:928802.
PMID: 35989933 PMC: 9389005. DOI: 10.3389/fneur.2022.928802.